Warning! GuruFocus detected
1 Medium warning sign
with 4595.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Mizuho Medy Co Ltd
ISIN : JP3885900005
Description
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.85 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.48 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.8 | |||||
| 3-Year EBITDA Growth Rate | 106.2 | |||||
| 3-Year EPS without NRI Growth Rate | 131 | |||||
| 3-Year FCF Growth Rate | 165.7 | |||||
| 3-Year Book Growth Rate | 60.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.03 | |||||
| 9-Day RSI | 35.3 | |||||
| 14-Day RSI | 38.06 | |||||
| 3-1 Month Momentum % | -3.2 | |||||
| 6-1 Month Momentum % | -13.16 | |||||
| 12-1 Month Momentum % | -14.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.97 | |||||
| Quick Ratio | 7.84 | |||||
| Cash Ratio | 6.26 | |||||
| Days Inventory | 202.67 | |||||
| Days Sales Outstanding | 102.02 | |||||
| Days Payable | 45.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 6.97 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 128.9 | |||||
| Forward Dividend Yield % | 5.92 | |||||
| 5-Year Yield-on-Cost % | 74.68 | |||||
| Shareholder Yield % | 6.84 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.07 | |||||
| Operating Margin % | 45.94 | |||||
| Net Margin % | 34.31 | |||||
| FCF Margin % | 27.51 | |||||
| ROE % | 25.19 | |||||
| ROA % | 21.02 | |||||
| ROIC % | 52.14 | |||||
| 3-Year ROIIC % | 200.8 | |||||
| ROC (Joel Greenblatt) % | 89.62 | |||||
| ROCE % | 31.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.49 | |||||
| PE Ratio without NRI | 7.49 | |||||
| Shiller PE Ratio | 13.24 | |||||
| Price-to-Owner-Earnings | 5.56 | |||||
| PEG Ratio | 0.13 | |||||
| PS Ratio | 2.57 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 1.69 | |||||
| Price-to-Free-Cash-Flow | 7.66 | |||||
| Price-to-Operating-Cash-Flow | 7.15 | |||||
| EV-to-EBIT | 3.16 | |||||
| EV-to-EBITDA | 3.16 | |||||
| EV-to-Revenue | 1.46 | |||||
| EV-to-FCF | 4.49 | |||||
| Price-to-GF-Value | 1.05 | |||||
| Price-to-Projected-FCF | 0.57 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.28 | |||||
| Price-to-Graham-Number | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 2.04 | |||||
| Price-to-Net-Cash | 3.22 | |||||
| Earnings Yield (Greenblatt) % | 31.64 | |||||
| FCF Yield % | 13.62 | |||||
| Forward Rate of Return (Yacktman) % | 20 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mizuho Medy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 11,082 | ||
| EPS (TTM) (円) | 199.613 | ||
| Beta | 0.46 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.96 | ||
| Volatility % | 14.62 | ||
| 14-Day RSI | 38.06 | ||
| 14-Day ATR (円) | 33.921934 | ||
| 20-Day SMA (円) | 1474.8 | ||
| 12-1 Month Momentum % | -14.59 | ||
| 52-Week Range (円) | 1341 - 1824 | ||
| Shares Outstanding (Mil) | 19.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mizuho Medy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mizuho Medy Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mizuho Medy Co Ltd Frequently Asked Questions
What is Mizuho Medy Co Ltd(TSE:4595)'s stock price today?
The current price of TSE:4595 is 円1405.00. The 52 week high of TSE:4595 is 円1824.00 and 52 week low is 円1341.00.
When is next earnings date of Mizuho Medy Co Ltd(TSE:4595)?
The next earnings date of Mizuho Medy Co Ltd(TSE:4595) is .
Does Mizuho Medy Co Ltd(TSE:4595) pay dividends? If so, how much?
The Dividend Yield %  of Mizuho Medy Co Ltd(TSE:4595) is 6.97% (As of Today), Highest Dividend Payout Ratio of Mizuho Medy Co Ltd(TSE:4595) was 0.4. The lowest was 0.17. And the median was 0.3. The  Forward Dividend Yield % of Mizuho Medy Co Ltd(TSE:4595) is 5.92%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers